This study is testing a new system designed to make donated red blood cells safer before they are given to patients who need transfusions. The system aims to reduce the risk of passing on infections like Zika virus through blood transfusions. The trial will compare the safety and…
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC